Prevalence of Anemia among Chronic Kidney Disease and Chronic Kidney Disease of unknown Etiology Patients of Bargarh District Odisha: A Cross Sectional Study
Article Sidebar
Main Article Content
Abstract
Introduction: Anemia is a known complication in Chronic Kidney Disease (CKD). Previous study carried out by our lab reported higher prevalence of CKD and Chronic Kidney Disease of Unknown Etiology (CKDu) in Bargarh district, Odisha, India and 16 hotspot villages were identified in the district. The present study focused on assessing the prevalence of anemia among CKD and CKDu patients.
Methods: A cross-sectional study was conducted in the CKD hotspot villages of Bargarh district. Random cluster sampling method was used to assess the prevalence of anemia among CKD and CKDu patients. Patients’ history was collected using questionnaire. Blood samples were collected from the participants, and were analyzed for serological and biochemical parameters: such as creatinine, albumin, cholesterol, Complete Blood Count.
Results: In this study higher number of patients with CKDu (89.17%) were found to be anemic than CKD (85.71%) patients. Males were seen to be more prone to anemia and CKDu. Microcytic anemia was noted to be higher in CKDu populace (57.96%). Majority of patients in this study were farmers. Late CKD stages were found to be associated with higher prevalence of anemia. Significant relation of diastolic blood pressure, serum albumin, cholesterol, serum creatinine and serum urea with hemoglobin was observed.
Conclusion: The present study demonstrates a high prevalence of anemia among patients with both CKD and CKDu in the Bargarh district of Odisha, with a notably higher burden observed in the CKDu group. The predominance of microcytic anemia, particularly among male agricultural workers, underscores the possible influence of environmental and occupational factors.
Article Details
Copyright (c) 2025 Shristi S, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7–11. Available from: https://doi.org/10.1016/j.kisu.2021.11.003
George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: The case for increased screening. BMJ Glob Health. 2017;2(2):e000256. Available from: https://doi.org/10.1136/bmjgh-2016-000256
Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017;2(2):e000380. Available from: https://doi.org/10.1136/bmjgh-2017-000380
Bikbov B, Purcell C, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. Available from: https://doi.org/10.1016/s0140-6736(20)30045-3
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH. Mesoamerican Nephropathy: Report from the First International Research Workshop on MeN. Am J Kidney Dis. 2013;63(3):396–404. Available from: https://doi.org/10.1053/j.ajkd.2013.08.014
Chandrajith R, Nanayakkara S, Itai K, Aturaliya TNC, Dissanayake CB, Abeysekera T, et al. Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: Geographic distribution and environmental implications. Environ Geochem Health. 2011;33(3):267–78. Available from: https://doi.org/10.1007/s10653-010-9339-1
Tatapudi RR, Rentala S, Gullipalli P, Komarraju AL, Singh AK, Tatapudi VS, et al. High Prevalence of CKD of Unknown Etiology in Uddanam, India. Kidney Int Rep. 2019;4(3):380–9. Available from: https://doi.org/10.1016/j.ekir.2018.10.006
Chowdhary P, Rathore V, Jain K, Galhotra A, Verma N, Kale SA, et al. CKD of Unknown Origin in Supebeda, Chhattisgarh, India. Kidney Int Rep. 2021;6(1):210–4. Available from: https://doi.org/10.1016/j.ekir.2020.10.007
Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, et al. Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44(1):94–111. Available from: https://doi.org/10.1053/j.ajkd.2004.03.023
Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002;162(12):1401–8. Available from: https://doi.org/10.1001/archinte.162.12.1401
Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943. Available from: https://doi.org/10.1371/journal.pone.0084943
Zaawari A, Tejaswini KL, Davina GD, Singanaveni A. Prevalence of anemia among chronic kidney disease patients in India: a single-centre study. Int J Basic Clin Pharmacol. 2022;11(5):404–9. Available from: https://doi.org/10.18203/2319-2003.ijbcp20222135
Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150. Available from: https://pure.johnshopkins.edu/en/publications/kidney-disease-improving-global-outcomes-kdigo-ckd-work-group-kdi-4
Sathyan S, George S, Vijayan P. Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study. Int J Adv Med. 2017;4(1):247–51. Available from: https://doi.org/10.18203/2349-3933.ijam20170120
Mishra SS, Sahu KA, Dungdung SM, Ahmed NS, Baitharu I. Pesticide pollution in freshwater and its impact on community health. In: Current Developments in Biotechnology and Bioengineering: Pesticides: Human Health, Environmental Impacts and Management. 2023.
Sahu AK, Dung MSD, Sahoo SK, Mir SA, Nayak B, Baitharu I. Ecological and human health risk associated with heavy metals in sediments and bioaccumulation in some commercially important fishes in Mahanadi River, Odisha, India. Environ Chem Ecotoxicol. 2023;5:100394. Available from: http://dx.doi.org/10.1016/j.enceco.2023.08.001
Cernaro V, Coppolino G, Visconti L, Rivoli L, Lacquaniti A, Santoro D, et al. Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements. Med Res Rev. 2019;39(1):427–60. Available from: https://doi.org/10.1002/med.21527
De Broe ME, Vervaet BA. Is an Environmental Nephrotoxin the Primary Cause of CKDu (Mesoamerican Nephropathy)? PRO. Kidney360. 2020;1(7):591–5. Available from: https://doi.org/10.34067/KID.0003172020
Bello AK, Peters J, Rigby J, Rahman AA, El Nahas M. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol. 2008;3(5):1316–23. Available from: https://doi.org/10.2215/cjn.00680208
Shen Y, Wang J, Yuan J, Yang L, Yu F, Wang X, et al. Anemia among Chinese patients with chronic kidney disease and its association with quality of life - results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2021;22(1):64. Available from: https://doi.org/10.1186/s12882-021-02247-8
Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, Obrador GT, et al. Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38(4):803-812. https://doi.org/10.1053/ajkd.2001.27699
Pavanello C, Ossoli A. HDL and chronic kidney disease. Atheroscler Plus. 2023;52:9–17. Available from: https://doi.org/10.1016/j.athplu.2023.04.001
Liang X, Ye M, Tao M, Zheng D, Cai R, Zhu Y, et al. The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: A retrospective study. BMC Nephrol. 2020;21(1):252. Available from: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-01907-5
Jayasumana C, Paranagama P, Agampodi S, Wijewardane C, Gunatilake S, Siribaddana S. Drinking well water and occupational exposure to Herbicides is associated with chronic kidney disease, in Padavi-Sripura, Sri Lanka. Environ Health. 2015;14(1):6. Available from: https://link.springer.com/article/10.1186/1476-069x-14-6
Singh AK, Farag YMK, Mittal BV, Subramanian KK, Reddy SRK, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India - Results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013;14(1):114. Available from: https://link.springer.com/article/10.1186/1471-2369-14-114